Pharma tariffs may go as high as 250%, says Trump

US President Donald Trump said Tuesday that upcoming tariffs on imported pharmaceuticals could go as high as 250 percent — after starting at a lower level — adding he plans to unveil fresh duties on foreign semiconductors.

“We’ll be putting (an) initially small tariff on pharmaceuticals, but in one year, one-and-a-half years, maximum, it’s going to go to 150 percent and then it’s going to go to 250 percent because we want pharmaceuticals made in our country,” Trump said in an interview on CNBC.

He did not say what the initial tariff rate on pharmaceuticals would be.

Trump said he would also announce tariffs on semiconductors and chips in the “next week or so” without elaborating.

The US president has threatened debilitating tariffs on the drug industry in an effort to force manufacturing back into the US. Trump recently demanded major suppliers of medicines drastically cut costs or face additional, unspecified penalties.

Related Posts

3-month relief: Final call for 10,000 pharmacists to renew registration

At least 70,000 pharmacists are registered in Haryana; of these, about 10,000 — whose registrations expired on December 31, 2020, — have not yet renewed The Haryana State Pharmacy Council…

Marksans Pharma gets USFDA nod for generic Benzonatate capsules

Marksans Pharma Ltd on Wednesday said it has received final approval from the US health regulator for its generic version of Benzonatate capsules indicated for treatment of persistent cough, bronchitis,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

3-month relief: Final call for 10,000 pharmacists to renew registration

3-month relief: Final call for 10,000 pharmacists to renew registration

Marksans Pharma gets USFDA nod for generic Benzonatate capsules

Marksans Pharma gets USFDA nod for generic Benzonatate capsules

Greatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’

Greatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’

Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test

Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test

Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

Haryana Mandates Real-Time Medicine Tracking In Govt Hospitals

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices